A 54-year-old woman is evaluated in the intensive care unit for worsening respiratory distress. She was admitted 48 hours ago for a severe right lower lobe community-acquired pneumonia and was started on intravenous ceftriaxone and azithromycin. Blood and sputum cultures drawn on admission are now growing *Streptococcus pneumoniae* susceptible to penicillin.
Current vital signs are:
Temperature: 38.9°C (102.0°F)
Pulse: 124/min
Blood pressure: 82/50 mmHg
Respirations: 32/min
SpO2: 87% on a high-flow nasal cannula (FiO2 60%)
Over the past 4 hours, she has received 3 L of intravenous normal saline without improvement in her blood pressure. Physical examination reveals cool, mottled extremities. Jugular venous pressure is 5 cm H2O. Pulmonary auscultation reveals diffuse bilateral crackles, a change from the isolated right-sided crackles noted on admission. A bedside chest radiograph demonstrates new, diffuse bilateral alveolar opacities in addition to the right lower lobe consolidation.
Laboratory results:
Leukocytes: 18,500/mm³
Serum sodium: 138 mEq/L
Serum potassium: 4.8 mEq/L
Serum chloride: 101 mEq/L
Serum bicarbonate: 13 mEq/L
Blood urea nitrogen: 34 mg/dL
Serum creatinine: 2.2 mg/dL
Serum lactate: 6.5 mmol/L
Arterial blood gas (on HFNC 60%):
pH: 7.20
PaCO2: 35 mmHg
PaO2: 55 mmHg
Which of the following statements regarding this patient's condition and management are correct? (Select all that apply)
- The patient has a mixed metabolic acidosis and concurrent respiratory acidosisAnswer
- Initiation of a continuous intravenous norepinephrine infusion is indicatedAnswer
- CIntravenous furosemide should be administered to treat the new bilateral alveolar opacities
- DAntibiotic therapy should be broadened to include intravenous vancomycin
- EThe arterial blood gas values indicate appropriate physiological respiratory compensation